| First Author | Worton LE | Year | 2018 |
| Journal | PLoS One | Volume | 13 |
| Issue | 11 | Pages | e0207354 |
| PubMed ID | 30427927 | Mgi Jnum | J:267332 |
| Mgi Id | MGI:6258838 | Doi | 10.1371/journal.pone.0207354 |
| Citation | Worton LE, et al. (2018) Botulinum toxin A-induced muscle paralysis stimulates Hdac4 and differential miRNA expression. PLoS One 13(11):e0207354 |
| abstractText | At sufficient dose, intramuscular injection of Botulinum toxin A causes muscle wasting that is physiologically consistent with surgical denervation and other types of neuromuscular dysfunction. The aim of this study was to clarify early molecular and micro-RNA alterations in skeletal muscle following Botulinum toxin A-induced muscle paralysis. Quadriceps were analyzed for changes in expression of micro- and messenger RNA and protein levels after a single injection of 0.4, 2 or 4U Botulinum toxin A (/100g body weight). After injection with 2.0U Botulinum toxin A, quadriceps exhibited significant reduction in muscle weight and increased levels of ubiquitin ligase proteins at 7, 14 and 28 days. Muscle miR-1 and miR-133a/b levels were decreased at these time points, whereas a dose-responsive increase in miR-206 expression at day 14 was observed. Expression of the miR-133a/b target genes RhoA, Tgfb1 and Ctfg, and the miR-1/206 target genes Igf-1 and Hdac4, were upregulated at 28 days after Botulinum toxin A injection. Increased levels of Hdac4 protein were observed after injection, consistent with anticipated expression changes in direct and indirect Hdac4 target genes, such as Myog. Our results suggest Botulinum toxin A-induced denervation of muscle shares molecular characteristics with surgical denervation and other types of neuromuscular dysfunction, and implicates miR-133/Tgf-beta1/Ctfg and miR-1/Hdac4/Myog signaling during the resultant muscle atrophy. |
